• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CTLA-4受体在T细胞活化和免疫中的作用。CTLA-4受体的生理功能。

Role of the CTLA-4 receptor in T cell activation and immunity. Physiologic function of the CTLA-4 receptor.

作者信息

Scheipers P, Reiser H

机构信息

Department of Immunology, Imperial College School of Medicine, Hammersmith Hospital, London, UK.

出版信息

Immunol Res. 1998;18(2):103-15. doi: 10.1007/BF02788753.

DOI:10.1007/BF02788753
PMID:9844829
Abstract

Costimulatory molecules of the B7 family regulate the activation of T lymphocytes. T cell activation is promoted by binding of B7 molecules to CD28 and inhibited by binding to CTLA-4 (CD152). The balance between positive signals through CD28 and negative signals through CTLA-4 is critical for the fate of the T cell and is subject to tight regulation. Recent in vitro and in vivo studies have significantly advanced our understanding of the function of the CTLA-4 receptor. The results of these experiments suggest that CTLA-4 is critical for the induction of self-tolerance, and that it may have distinct signaling functions in resting and activated T cells. In resting T cells, CTLA-4 crosslinking leads to cell-cycle arrest, whereas in activated T cells, CTLA-4 crosslinking induces apoptosis. In this article, we will review the physiologic functions of the CTLA-4 receptor.

摘要

B7家族的共刺激分子调节T淋巴细胞的激活。B7分子与CD28结合可促进T细胞激活,而与CTLA-4(CD152)结合则抑制T细胞激活。通过CD28的正向信号与通过CTLA-4的负向信号之间的平衡对于T细胞的命运至关重要,且受到严格调控。近期的体外和体内研究极大地推进了我们对CTLA-4受体功能的理解。这些实验结果表明,CTLA-4对于诱导自身耐受至关重要,并且它在静息和活化的T细胞中可能具有不同的信号传导功能。在静息T细胞中,CTLA-4交联导致细胞周期停滞,而在活化T细胞中,CTLA-4交联诱导细胞凋亡。在本文中,我们将综述CTLA-4受体的生理功能。

相似文献

1
Role of the CTLA-4 receptor in T cell activation and immunity. Physiologic function of the CTLA-4 receptor.CTLA-4受体在T细胞活化和免疫中的作用。CTLA-4受体的生理功能。
Immunol Res. 1998;18(2):103-15. doi: 10.1007/BF02788753.
2
CTLA-4 and T cell activation.细胞毒性T淋巴细胞相关抗原4与T细胞活化
Curr Opin Immunol. 1999 Jun;11(3):294-300. doi: 10.1016/s0952-7915(99)80047-8.
3
[Regulation of T-cell activation by CD28 and CTLA-4].[CD28和CTLA-4对T细胞活化的调节]
Med Klin (Munich). 1998 Oct 15;93(10):592-7. doi: 10.1007/BF03042674.
4
Is CTLA-4 a master switch for peripheral T cell tolerance?细胞毒性T淋巴细胞相关抗原4(CTLA-4)是外周T细胞耐受的主控开关吗?
J Immunol. 1997 Mar 1;158(5):1989-93.
5
Expression and functional significance of CTLA-4, a negative regulator of T cell activation.T细胞活化负调节因子CTLA-4的表达及功能意义
Arch Immunol Ther Exp (Warsz). 2001;49(1):39-46.
6
Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation.活化的人类B淋巴细胞表达三种共刺激T细胞活化的CTLA-4反受体。
Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11059-63. doi: 10.1073/pnas.90.23.11059.
7
B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.在慢性实验性结肠炎中,B7与CD28和CTLA-4的相互作用控制着耐受性或黏膜炎症的诱导。
J Immunol. 2001 Aug 1;167(3):1830-8. doi: 10.4049/jimmunol.167.3.1830.
8
Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement.体内外周T细胞耐受性的诱导需要CTLA-4参与。
Immunity. 1997 Apr;6(4):411-7. doi: 10.1016/s1074-7613(00)80284-8.
9
Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.CTLA-4与CD28在活化T淋巴细胞上的共表达及功能协同作用。
J Exp Med. 1992 Dec 1;176(6):1595-604. doi: 10.1084/jem.176.6.1595.
10
CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells.CTLA-4的结合会抑制静息T细胞激活时IL-2的积累和细胞周期进程。
J Exp Med. 1996 Jun 1;183(6):2533-40. doi: 10.1084/jem.183.6.2533.

引用本文的文献

1
Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches.癌症中的免疫逃逸:机制与前沿治疗方法。
Signal Transduct Target Ther. 2025 Jul 31;10(1):227. doi: 10.1038/s41392-025-02280-1.
2
Immunotherapy-Related Hypophysitis: A Narrative Review.免疫治疗相关垂体炎:一篇叙述性综述
Cancers (Basel). 2025 Jan 27;17(3):436. doi: 10.3390/cancers17030436.
3
Photothermal therapies to improve immune checkpoint blockade for cancer.光热疗法增强癌症免疫检查点阻断治疗。

本文引用的文献

1
Expression and function of CTLA-4 in Th1 and Th2 cells.CTLA-4在Th1和Th2细胞中的表达及功能
J Immunol. 1998 Oct 1;161(7):3347-56.
2
Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally.对小鼠半胱天冬酶8基因进行靶向破坏,可消除肿瘤坏死因子受体、Fas/Apo1和DR3诱导的细胞死亡,且在出生前是致死性的。
Immunity. 1998 Aug;9(2):267-76. doi: 10.1016/s1074-7613(00)80609-3.
3
Src family tyrosine kinases associate with and phosphorylate CTLA-4 (CD152).Src家族酪氨酸激酶与CTLA-4(CD152)结合并使其磷酸化。
Int J Hyperthermia. 2020 Dec;37(3):34-49. doi: 10.1080/02656736.2020.1797190.
4
Itch regulation of innate and adaptive immune responses in mice and humans.鼠类和人类固有免疫与适应性免疫应答的瘙痒调控。
J Leukoc Biol. 2020 Jul;108(1):353-362. doi: 10.1002/JLB.3MIR0320-272R. Epub 2020 Apr 30.
5
NK Cell-Based Immune Checkpoint Inhibition.基于自然杀伤细胞的免疫检查点抑制。
Front Immunol. 2020 Feb 13;11:167. doi: 10.3389/fimmu.2020.00167. eCollection 2020.
6
Identifying and managing the adverse effects of immune checkpoint blockade.识别和管理免疫检查点阻断的不良反应。
J Thorac Dis. 2018 Feb;10(Suppl 3):S480-S489. doi: 10.21037/jtd.2018.01.111.
7
Targeting Angiotensin II Type-1 Receptor (ATR) Inhibits the Harmful Phenotype of -Specific CD8 T Cells during Blood-Stage Malaria.靶向血管紧张素II 1型受体(ATR)可抑制血液期疟疾期间特异性CD8 T细胞的有害表型。
Front Cell Infect Microbiol. 2017 Feb 16;7:42. doi: 10.3389/fcimb.2017.00042. eCollection 2017.
8
Current and emerging treatment options in the management of lupus.狼疮治疗中的现有及新出现的治疗选择。
Immunotargets Ther. 2016 Mar 2;5:9-20. doi: 10.2147/ITT.S40675. eCollection 2016.
9
Key issues in the management of patients with systemic lupus erythematosus: latest developments and clinical implications.系统性红斑狼疮患者管理中的关键问题:最新进展及临床意义
Ther Adv Musculoskelet Dis. 2015 Dec;7(6):234-46. doi: 10.1177/1759720X15601805.
10
Novel therapeutic agents in clinical development for systemic lupus erythematosus.正在临床开发用于系统性红斑狼疮的新型治疗药物。
BMC Med. 2013 May 3;11:120. doi: 10.1186/1741-7015-11-120.
Biochem Biophys Res Commun. 1998 Aug 19;249(2):444-8. doi: 10.1006/bbrc.1998.9191.
4
Differential requirement for caspase 9 in apoptotic pathways in vivo.体内凋亡途径中半胱天冬酶9的差异需求。
Cell. 1998 Aug 7;94(3):339-52. doi: 10.1016/s0092-8674(00)81477-4.
5
Fas-independent death of activated CD4(+) T lymphocytes induced by CTLA-4 crosslinking.CTLA-4交联诱导的活化CD4(+) T淋巴细胞的Fas非依赖性死亡。
Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):10083-8. doi: 10.1073/pnas.95.17.10083.
6
B7-1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28.细胞毒性T淋巴细胞抗原4与B7-1结合在缺乏CD28的情况下会抑制T细胞活化。
J Exp Med. 1998 Jul 6;188(1):205-10. doi: 10.1084/jem.188.1.205.
7
Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28.细胞毒性T淋巴细胞相关抗原4(CTLA4)阻断加速了CD28缺陷小鼠心脏同种异体移植的急性排斥反应:CTLA4可独立于CD28发挥作用。
J Exp Med. 1998 Jul 6;188(1):199-204. doi: 10.1084/jem.188.1.199.
8
Potent inhibition of CTLA-4 expression by an anti-CTLA-4 ribozyme.一种抗CTLA-4核酶对CTLA-4表达的强效抑制作用。
Biochem Biophys Res Commun. 1998 Jun 29;247(3):838-43. doi: 10.1006/bbrc.1998.8889.
9
Non-responsiveness of antigen-experienced CD4 T cells reflects more stringent co-stimulatory requirements.抗原致敏的CD4 T细胞无反应性反映了更严格的共刺激需求。
Immunology. 1998 Mar;93(3):366-75. doi: 10.1046/j.1365-2567.1998.00443.x.
10
Differential involvement of a Fas-CPP32-like protease pathway in apoptosis of TCR/CD9-costimulated, naive T cells and TCR-restimulated, activated T cells.Fas-CPP32样蛋白酶途径在TCR/CD9共刺激的初始T细胞和TCR再刺激的活化T细胞凋亡中的差异参与。
J Immunol. 1998 Jun 15;160(12):5790-6.